Skip Main Navigation

Steven Gullans, PhD

Steven Gullans, PhD

Managing Director Excel Medical Ventures

Steve Gullans, PhD, Managing Director, is an experienced investor, entrepreneur, scientist and author. At Excel, he focuses on life science technology companies with a particular interest in disruptive platforms that can impact multiple industries. Steve is currently a Board Director at Gemphire Therapeutics [NASDAQ: GEMP], Molecular Templates, N-of-One, Orionis Biosciences, and Cleveland HeartLab.  He was previously a board member of Activate Networks (acquired by Decision Resource Group}, BioTrove {acquired by Life Technologies), Biocius (acquired by Agilent), nanoMR (acquired by DNAe), and Tetraphase [NASAQ: TTPH].

Prior to Excel, Steve co-founded RxGen, Inc., a pharma services company where he served as CEO. For nearly 20 years, Steve was a faculty member at Harvard Medical School and Brigham and Women's Hospital where he published more than 130 scientific papers, lectured internationally, and co-invented numerous patents. With Juan Enriquez, Steve co- authored  “Evolving Ourselves: How Unnatural Selection and Non-Random Mutation are Changing Life on Earth”, which describes a how humans increasingly shape their environment, themselves, and other species. Steve is a Fellow of the AAAS and the AHA.

External Selection Committee (ESC)

End of main page content.